Clinical Trial Update: REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients [NA]

View source ↗

Summary

The REVERT study is a targeted therapy trial for advanced colorectal cancer that has completed, though no results are provided in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University of Rome Tor Vergata | Conditions: Metastatic Colon Cancer | NA | Status: COMPLETED